Is Pazopanib launched in China?
Pazopanib/Pazopanibin2017year3month

Pazopanib is a multikinase inhibitor that inhibits vascular endothelial growth factor receptor (VEGFR), platelet-derived growth factor receptor (PDGF Enzymes such as R), c-KIT and FGFR target angiogenesis to limit tumor growth. The oral bioavailability of pazopanib is 21% and the inter-human bioavailability range is 14–39%. It reaches maximum concentration in plasma after a median 3.5 hours, with a study range of 1.0 to 11.9 hours. Compared with a single dose, the area under the curve (AUC) increased 1.23 to 4 times when taken regularly. Taking the drug with food approximately doubles the AUC and maximum plasma concentration (Cmax); crushing the tablets AUC increased 1.46 times, and Cmax also doubled. While in the bloodstream, more than 99.5%of the substance is bound to plasma proteins. The liver enzymes primarily responsible for metabolizing drugs are CYP3A4CYP1A2 and CYP2C8 also contribute a small amount. Metabolites found in tests on human liver cells and microsomes included various hydroxyl derivatives and possibly a carboxylic acid. Only6%of circulating substances exist in the form of metabolites, all but one of which are 10-20 times less active than pazopanib itself. Therefore, metabolites are not considered important for the therapeutic effect of the drug. There are generic drugs in Bangladesh, and the retail price of Bangladesh Yaopin International Pharmaceuticals is about 200mg 30 tablets600 yuan. If you want to get more high-quality information, you can contact YaDE. YaDE will do its best to learn more about high-quality overseas drugs for you.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)